Validation of HyperDetector for SARS-CoV-2

Status Suspended

Clinical Trial Summary

To evaluate the HyperDetector as a method to rapidly screen SARS-CoV-2 To determine the sensitivity and specificity of the screening assay performed on oral swab and saliva specimens, compared to a validated RT-PCR COVID-19 method using nasal or nasopharyngeal swabs and to separately collected nasal swabs, oral swabs, oral rinse and saliva samples. To determine the best workflow for using such an assay to reflex suspicious/positive samples to a validated RT-PCR COVID-19 assay.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05124496
Study type	Observational
Source	HyperSpectral APD
Contact
Status	Suspended
Phase
Start date	December 11, 2020
Completion date	December 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04979858` - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask	N/A
Recruiting	`NCT05311410` - Viral Kinetics of SARS-CoV-2 in Patients With COVID-19 in the Intensive Care Unit Undergoing Dental Procedures	N/A
Active, not recruiting	`NCT05073718` - SARS-CoV-2 and Acetylsalicylic Acid (SARA)	Phase 3
Completed	`NCT05055505` - The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions	N/A
Completed	`NCT05060510` - The School SPIT Study - COVID-19 Testing in Secondary Schools	N/A
Completed	`NCT05055492` - The School SPIT Study - Elementary Schools in High COVID-19 Incidence Regions	N/A
Completed	`NCT05054218` - COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients
Completed	`NCT05449392` - Topical Antibacterial Agents for Prevention of COVID-19	Phase 1
Completed	`NCT05076253` - Efficacy of Ivermectin in COVID-19	Phase 1/Phase 2
Recruiting	`NCT05172024` - Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
Terminated	`NCT05593770` - International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response	Phase 2/Phase 3
Completed	`NCT05030974` - RECOVAC Repeated Vaccination Study	Phase 4
Withdrawn	`NCT05067946` - Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines	Phase 2/Phase 3
Not yet recruiting	`NCT05013034` - Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients	Phase 2
Withdrawn	`NCT05393999` - SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations	Phase 2
Recruiting	`NCT05047783` - Masitinib in Patients With Symptomatic Mild to Moderate COVID-19	Phase 2
Not yet recruiting	`NCT05116657` - Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway Microbiome
Recruiting	`NCT04590222` - Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
Completed	`NCT04953039` - Use of Saliva for COVID-19 Diagnosis
Recruiting	`NCT04999098` - Echinaforce COVID-19 Shedding Study	Phase 4